インフルエンザウイルスヘマグルチニンについてのアッセイ

Title:

インフルエンザウイルスヘマグルチニンについてのアッセイ

Document Type and Number:

Japanese Patent JP2012528139

Kind Code:

A

Abstract:

A combination of ultrafiltration and HPLC is used to analyze influenza virus. This combination is able to quantify hemagglutinin (HA) and correlates well with single radial immunodiffusion (SRID) results, but can be performed without the delay of waiting for immunochemical SRID reagents.

More Like This:

JP2009528305	Chimeric vaccine antigen against avian influenza virus
WO2007022425	INFLUENZA RECOMBINANT SUBUNIT VACCINE
JP2000253876	VACCINE USING SENDAI VIRUS VECTOR, AND VACCINE PROTEIN

Inventors:

Dormitcher, Philip
Wen, insha
Palmer, Jean
Paella, Linera
Woo pin

Application Number:

JP2012512471A

Publication Date:

November 12, 2012

Filing Date:

May 28, 2010

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Novartis Age

International Classes:

C07K14/11; A61K39/145; G01N30/88

Domestic Patent References:

JP2004123749A	2004-04-22
JPH10504033A	1998-04-14

Foreign References:

WO2007011904A2

2007-01-25

Other References:

JPN6014035334; Ｖａｃｃｉｎｅ，　２００８（ｏｎｌｉｎｅ），　Ｖｏｌ．２７，　ｐ．１４６８-１４７７
JPN6014035335; Ｖａｃｃｉｎｅ，　２００６，　Ｖｏｌ．２４，　ｐ．３１３７-３１４４

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: 新規のペプチド、その調製プロセス、及びその使用

Next Patent: 新規なグルココルチコイド受容体アゴニスト